Erratum: ERß Impedes Prostate Cancer EMT by Destabilizing HIF-1a and Inhibiting VEGF-Mediated Snail Nuclear Localization: Implications for Gleason Grading (DOI:10.1016/j.ccr.2010.02.030);ERβ Impedes Prostate Cancer EMT by Destabilizing HIF-1α and Inhibiting VEGF-Mediated Snail Nuclear Localization: Implications for Gleason Grading

Cancer Cell

Volumn 17, Issue 4, 2010, Pages 319-332

  Mak, Paul ^a   Leav, Irwin ^a   Pursell, Bryan ^a   Bae, Donggoo ^a   Yang, Xiaofang ^a   Taglienti, Cherie A ^a   Gouvin, Lindsey M ^a   Sharma, Vishva M ^a   Mercurio, Arthur M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

CELLCYCLE; DNA; SIGNALING

Indexed keywords

3BETA ANDROSTANEDIOL; ESTROGEN RECEPTOR BETA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NEUROPILIN 1; PROTEIN; SNAIL1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN; HIF1A PROTEIN, HUMAN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR; VASCULOTROPIN A;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG INHIBITION; EPITHELIUM; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; MALE; MESENCHYME; NUCLEAR LOCALIZATION SIGNAL; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; CYTOLOGY; EPITHELIUM CELL; MESODERM; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR;

GASTROPODA;

EPITHELIAL CELLS; ESTROGEN RECEPTOR BETA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MESODERM; PROSTATIC NEOPLASMS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77950476293     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2010.05.005     Document Type: Erratum

References (72)

1. Acevedo V.D., Gangula R.D., Freeman K.W., Li R., Zhang Y., Wang F., Ayala G.E., Peterson L.E., Ittmann M., and Spencer D.M. Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition. Cancer Cell 12 (2007) 559-571
2. Andriole G.L., Crawford E.D., Grubb III R.L., Buys S.S., Chia D., Church T.R., Fouad M.N., Gelmann E.P., Kvale P.A., Reding D.J., et al. Mortality results from a randomized prostate-cancer screening trial. N. Engl. J. Med. 360 (2009) 1310-1319
3. Bachelder R.E., Crago A., Chung J., Wendt M.A., Shaw L.M., Robinson G., and Mercurio A.M. Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res. 61 (2001) 5736-5740
4. Bachelder R.E., Yoon S.O., Franci C., de Herreros A.G., and Mercurio A.M. Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition. J. Cell Biol. 168 (2005) 29-33
5. Bae D., Lu S., Taglienti C.A., and Mercurio A.M. Metabolic stress induces the lysosomal degradation of neuropilin-1 but not neuropilin-2. J. Biol. Chem. 283 (2008) 28074-28080
6. Bates R.C., Goldsmith J.D., Bachelder R.E., Brown C., Shibuya M., Oettgen P., and Mercurio A.M. Flt-1 (VEGFR-1)-dependent survival characterizes the epithelial-mesenchymal transition of colonic organoids. Curr. Biol. 13 (2003) 1721-1727
7. Blanco M.J., Moreno-Bueno G., Sarrio D., Locascio A., Cano A., Palacios J., and Nieto M.A. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 21 (2002) 3241-3246
8. Brown J.M. The hypoxic cell: a target for selective cancer therapy-eighteenth Bruce F. Cain Memorial Award lecture. Cancer Res. 59 (1999) 5863-5870
9. Buteau-Lozano H., Ancelin M., Lardeux B., Milanini J., and Perrot-Applanat M. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Cancer Res. 62 (2002) 4977-4984
10. Cao Y., Wang L., Nandy D., Zhang Y., Basu A., Radisky D., and Mukhopadhyay D. Neuropilin-1 upholds dedifferentiation and propagation phenotypes of renal cell carcinoma cells by activating Akt and sonic hedgehog axes. Cancer Res. 68 (2008) 8667-8672
11. Castro-Rivera E., Ran S., Thorpe P., and Minna J.D. Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect. Proc. Natl. Acad. Sci. USA 101 (2004) 11432-11437
12. Caunt M., Mak J., Liang W.C., Stawicki S., Pan Q., Tong R.K., Kowalski J., Ho C., Reslan H.B., Ross J., et al. Blocking neuropilin-2 function inhibits tumor cell metastasis. Cancer Cell 13 (2008) 331-342
13. Compton D.R., Sheng S., Carlson K.E., Rebacz N.A., Lee I.Y., Katzenellenbogen B.S., and Katzenellenbogen J.A. Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity. J. Med. Chem. 47 (2004) 5872-5893
14. Dhasarathy A., Kajita M., and Wade P.A. The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha. Mol. Endocrinol. 21 (2007) 2907-2918
15. Doble B.W., and Woodgett J.R. GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116 (2003) 1175-1186
16. Dominguez D., Montserrat-Sentis B., Virgos-Soler A., Guaita S., Grueso J., Porta M., Puig I., Baulida J., Franci C., and Garcia de Herreros A. Phosphorylation regulates the subcellular location and activity of the snail transcriptional repressor. Mol. Cell. Biol. 23 (2003) 5078-5089
17. Egevad L. Recent trends in Gleason grading of prostate cancer: I. Pattern interpretation. Anal. Quant. Cytol. Histol. 30 (2008) 190-198
18. Egevad L. Recent trends in gleason grading of prostate cancer. II. Prognosis, reproducibility and reporting. Anal. Quant. Cytol. Histol. 30 (2008) 254-260
19. Epstein J.I., Allsbrook Jr. W.C., Amin M.B., and Egevad L.L. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am. J. Surg. Pathol. 29 (2005) 1228-1242
20. Fearon E.R. Connecting estrogen receptor function, transcriptional repression, and E-cadherin expression in breast cancer. Cancer Cell 3 (2003) 307-310
21. Ferrara N. VEGF as a therapeutic target in cancer. Oncology 69 Suppl 3 (2005) 11-16
22. Fujita N., Jaye D.L., Kajita M., Geigerman C., Moreno C.S., and Wade P.A. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 113 (2003) 207-219
23. Girault I., Lerebours F., Amarir S., Tozlu S., Tubiana-Hulin M., Lidereau R., and Bieche I. Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen. Clin. Cancer Res. 9 (2003) 1259-1266
24. Gleason D.F., and Mellinger G.T. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J. Urol. 111 (1974) 58-64
25. Gravdal K., Halvorsen O.J., Haukaas S.A., and Akslen L.A. A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin. Cancer Res. 13 (2007) 7003-7011
26. Gray M.J., Van Buren G., Dallas N.A., Xia L., Wang X., Yang A.D., Somcio R.J., Lin Y.G., Lim S., Fan F., et al. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver. J. Natl. Cancer Inst. 100 (2008) 109-120
27. Guerini V., Sau D., Scaccianoce E., Rusmini P., Ciana P., Maggi A., Martini P.G., Katzenellenbogen B.S., Martini L., Motta M., and Poletti A. The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype. Cancer Res. 65 (2005) 5445-5453
28. Guttmann-Raviv N., Kessler O., Shraga-Heled N., Lange T., Herzog Y., and Neufeld G. The neuropilins and their role in tumorigenesis and tumor progression. Cancer Lett. 231 (2006) 1-11
29. Harris A.L. Hypoxia-a key regulatory factor in tumour growth. Nat. Rev. Cancer 2 (2002) 38-47
30. Higgins D.F., Kimura K., Bernhardt W.M., Shrimanker N., Akai Y., Hohenstein B., Saito Y., Johnson R.S., Kretzler M., Cohen C.D., et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J. Clin. Invest. 117 (2007) 3810-3820
31. Horvath L.G., Henshall S.M., Lee C.S., Head D.R., Quinn D.I., Makela S., Delprado W., Golovsky D., Brenner P.C., O'Neill G., et al. Frequent loss of estrogen receptor-beta expression in prostate cancer. Cancer Res. 61 (2001) 5331-5335
32. Hyder S.M. Sex-steroid regulation of vascular endothelial growth factor in breast cancer. Endocr. Relat. Cancer 13 (2006) 667-687
33. Imamov O., Morani A., Shim G.J., Omoto Y., Thulin-Andersson C., Warner M., and Gustafsson J.A. Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate. Proc. Natl. Acad. Sci. USA 101 (2004) 9375-9380
34. Kong D., Li Y., Wang Z., Banerjee S., Ahmad A., Kim H.R., and Sarkar F.H. miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells 27 (2009) 1712-1721
35. Kuiper G.G., and Gustafsson J.A. The novel estrogen receptor-beta subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens. FEBS Lett. 410 (1997) 87-90
36. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., and Gustafsson J.A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138 (1997) 863-870
37. Latil A., Bieche I., Pesche S., Valeri A., Fournier G., Cussenot O., and Lidereau R. VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms. Int. J. Cancer 89 (2000) 167-171
38. Lau K.M., LaSpina M., Long J., and Ho S.M. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation. Cancer Res. 60 (2000) 3175-3182
39. Leav I., Lau K.M., Adams J.Y., McNeal J.E., Taplin M.E., Wang J., Singh H., and Ho S.M. Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am. J. Pathol. 159 (2001) 79-92
40. Lester R.D., Jo M., Montel V., Takimoto S., and Gonias S.L. uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells. J. Cell Biol. 178 (2007) 425-436
41. Leung Y.K., Mak P., Hassan S., and Ho S.M. Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling. Proc. Natl. Acad. Sci. USA 103 (2006) 13162-13167
42. Liao D., and Johnson R.S. Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev. 26 (2007) 281-290
43. Lim W., Cho J., Kwon H.Y., Park Y., Rhyu M.R., and Lee Y. Hypoxia-inducible factor 1 alpha activates and is inhibited by unoccupied estrogen receptor beta. FEBS Lett. 583 (2009) 1314-1318
44. Loric S., Paradis V., Gala J.L., Berteau P., Bedossa P., Benoit G., and Eschwege P. Abnormal E-cadherin expression and prostate cell blood dissemination as markers of biological recurrence in cancer. Eur. J. Cancer 37 (2001) 1475-1481
45. Mak P., Leung Y.K., Tang W.Y., Harwood C., and Ho S.M. Apigenin suppresses cancer cell growth through ERbeta. Neoplasia 8 (2006) 896-904
46. Miao H.Q., Lee P., Lin H., Soker S., and Klagsbrun M. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. FASEB J. 14 (2000) 2532-2539
47. Moody S.E., Perez D., Pan T.C., Sarkisian C.J., Portocarrero C.P., Sterner C.J., Notorfrancesco K.L., Cardiff R.D., and Chodosh L.A. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 8 (2005) 197-209
48. Morani A., Warner M., and Gustafsson J.A. Biological functions and clinical implications of oestrogen receptors alfa and beta in epithelial tissues. J. Intern. Med. 264 (2008) 128-142
49. Nanni S., Benvenuti V., Grasselli A., Priolo C., Aiello A., Mattiussi S., Colussi C., Lirangi V., Illi B., D'Eletto M., et al. Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer. J. Clin. Invest. 119 (2009) 1093-1108
50. Oliveira A.G., Coelho P.H., Guedes F.D., Mahecha G.A., Hess R.A., and Oliveira C.A. 5alpha-Androstane-3beta,17beta-diol (3beta-diol), an estrogenic metabolite of 5alpha-dihydrotestosterone, is a potent modulator of estrogen receptor ERbeta expression in the ventral prostrate of adult rats. Steroids 72 (2007) 914-922
51. Pan Q., Chanthery Y., Liang W.C., Stawicki S., Mak J., Rathore N., Tong R.K., Kowalski J., Yee S.F., Pacheco G., et al. Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth. Cancer Cell 11 (2007) 53-67
52. Prins G.S., and Korach K.S. The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 73 (2008) 233-244
53. Prins G.S., Marmer M., Woodham C., Chang W., Kuiper G., Gustafsson J.A., and Birch L. Estrogen receptor-beta messenger ribonucleic acid ontogeny in the prostate of normal and neonatally estrogenized rats. Endocrinology 139 (1998) 874-883
54. Pritchard C., Mecham B., Dumpit R., Coleman I., Bhattacharjee M., Chen Q., Sikes R.A., and Nelson P.S. Conserved gene expression programs integrate mammalian prostate development and tumorigenesis. Cancer Res. 69 (2009) 1739-1747
55. Schroder F.H., Hugosson J., Roobol M.J., Tammela T.L., Ciatto S., Nelen V., Kwiatkowski M., Lujan M., Lilja H., Zappa M., et al. Screening and prostate-cancer mortality in a randomized European study. N. Engl. J. Med. 360 (2009) 1320-1328
56. Shaw L.M., Rabinovitz I., Wang H.H., Toker A., and Mercurio A.M. Activation of phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinoma invasion. Cell 91 (1997) 949-960
57. Soker S., Takashima S., Miao H.Q., Neufeld G., and Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform- specific receptor for vascular endothelial growth factor. Cell 92 (1998) 735-745
58. Stevens A., Soden J., Brenchley P.E., Ralph S., and Ray D.W. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res. 63 (2003) 812-816
59. Stoner M., Wormke M., Saville B., Samudio I., Qin C., Abdelrahim M., and Safe S. Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins. Oncogene 23 (2004) 1052-1063
60. Su J.L., Yang P.C., Shih J.Y., Yang C.Y., Wei L.H., Hsieh C.Y., Chou C.H., Jeng Y.M., Wang M.Y., Chang K.J., et al. The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell 9 (2006) 209-223
61. Tomita K., van Bokhoven A., van Leenders G.J., Ruijter E.T., Jansen C.F., Bussemakers M.J., and Schalken J.A. Cadherin switching in human prostate cancer progression. Cancer Res. 60 (2000) 3650-3654
62. Trpkov K., Zhang J., Chan M., Eigl B.J., and Yilmaz A. Prostate cancer with tertiary Gleason pattern 5 in prostate needle biopsy: clinicopathologic findings and disease progression. Am. J. Surg. Pathol. 33 (2009) 233-240
63. Voigt K.D., and Bartsch W. Intratissular androgens in benign prostatic hyperplasia and prostatic cancer. J. Steroid Biochem. 25 (1986) 749-757
64. Wanami L.S., Chen H.Y., Peiro S., Garcia de Herreros A., and Bachelder R.E. Vascular endothelial growth factor-A stimulates Snail expression in breast tumor cells: implications for tumor progression. Exp. Cell Res. 314 (2008) 2448-2453
65. Wang X., Belguise K., Kersual N., Kirsch K.H., Mineva N.D., Galtier F., Chalbos D., and Sonenshein G.E. Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2. Nat. Cell Biol. 9 (2007) 470-478
66. Wu Y., Deng J., Rychahou P.G., Qiu S., Evers B.M., and Zhou B.P. Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 15 (2009) 416-428
67. Yang J., and Weinberg R.A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 14 (2008) 818-829
68. Yang A.D., Camp E.R., Fan F., Shen L., Gray M.J., Liu W., Somcio R., Bauer T.W., Wu Y., Hicklin D.J., and Ellis L.M. Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells. Cancer Res. 66 (2006) 46-51
69. Yook J.I., Li X.Y., Ota I., Fearon E.R., and Weiss S.J. Wnt-dependent regulation of the E-cadherin repressor snail. J. Biol. Chem. 280 (2005) 11740-11748
70. Yook J.I., Li X.Y., Ota I., Hu C., Kim H.S., Kim N.H., Cha S.Y., Ryu J.K., Choi Y.J., Kim J., et al. A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. Nat. Cell Biol. 8 (2006) 1398-1406
71. Zhou B.P., Deng J., Xia W., Xu J., Li Y.M., Gunduz M., and Hung M.C. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat. Cell Biol. 6 (2004) 931-940
72. Zhu X., Leav I., Leung Y.K., Wu M., Liu Q., Gao Y., McNeal J.E., and Ho S.M. Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis. Am. J. Pathol. 164 (2004) 2003-2012